Molecular Pharmaceutics
Article
(
10) Maxwell, P. R.; Timms, P. M.; Chandran, S.; Gordon, D.
generation of a hydrophobic product from a noninhibitory protease
substrate. Clin. Cancer Res. 2012, 18 (1), 238−47.
Peripheral blood level alterations of TIMP-1, MMP-2 and MMP-9 in
patients with type 1 diabetes. Diabet. Med. 2001, 18 (10), 777−80.
(
receptor cleavage: mechanism for insulin resistance in the sponta-
neously hypertensive rat. Hypertension 2008, 52 (2), 415−23.
(
(26) Matsuo, K.; Kamada, R.; Mizusawa, K.; Imai, H.; Takayama, Y.;
Narazaki, M.; Matsuda, T.; Takaoka, Y.; Hamachi, I. Specific detection
and imaging of enzyme activity by signal-amplifiable self-assembling
11) DeLano, F. A.; Schmid-Schonbein, G. W. Proteinase activity and
19
F MRI probes. Chemistry 2013, 19 (38), 12875−83.
12) Friese, R. S.; Rao, F.; Khandrika, S.; Thomas, B.; Ziegler, M. G.;
(27) Mizukami, S.; Takikawa, R.; Sugihara, F.; Shirakawa, M.;
Schmid-Schonbein, G. W.; O’Connor, D. T. Matrix metalloprotei-
nases: discrete elevations in essential hypertension and hypertensive
end-stage renal disease. Clin. Exp. Hypertens. 2009, 31 (7), 521−33.
Kikuchi, K. Dual-function probe to detect protease activity for
fluorescence measurement and 19F MRI. Angew. Chem., Int. Ed. 2009,
48 (20), 3641−3.
(
13) Zhang, Z.; Fan, J.; Cheney, P. P.; Berezin, M. Y.; Edwards, W.
(28) Mizukami, S.; Takikawa, R.; Sugihara, F.; Hori, Y.; Tochio, H.;
Walchli, M.; Shirakawa, M.; Kikuchi, K. Paramagnetic relaxation-based
B.; Akers, W. J.; Shen, D.; Liang, K.; Culver, J. P.; Achilefu, S.
Activatable molecular systems using homologous near-infrared
fluorescent probes for monitoring enzyme activities in vitro, in cellulo,
and in vivo. Mol. Pharmaceutics 2009, 6 (2), 416−27.
19
F MRI probe to detect protease activity. J. Am. Chem. Soc. 2008, 130
(3), 794−5.
(29) Takaoka, Y.; Kiminami, K.; Mizusawa, K.; Matsuo, K.; Narazaki,
M.; Matsuda, T.; Hamachi, I. Systematic study of protein detection
mechanism of self-assembling 19F NMR/MRI nanoprobes toward
rational design and improved sensitivity. J. Am. Chem. Soc. 2011, 133
(30), 11725−31.
(
14) Zhu, L.; Zhang, F.; Ma, Y.; Liu, G.; Kim, K.; Fang, X.; Lee, S.;
Chen, X. In vivo optical imaging of membrane-type matrix
metalloproteinase (MT-MMP) activity. Mol. Pharmaceutics 2011, 8
(
6), 2331−8.
(
30) Ahrens, E. T.; Bulte, J. W. Tracking immune cells in vivo using
magnetic resonance imaging. Nat. Rev. Immunol. 2013, 13 (10), 755−
3.
31) Schmieder, A. H.; Wang, K.; Zhang, H.; Senpan, A.; Pan, D.;
(
15) Cai, Y.; Zhu, L.; Zhang, F.; Niu, G.; Lee, S.; Kimura, S.; Chen, X.
Noninvasive monitoring of pulmonary fibrosis by targeting matrix
6
(
metalloproteinases (MMPs). Mol. Pharmaceutics 2013, 10 (6), 2237−
47.
Keupp, J.; Caruthers, S. D.; Wickline, S. A.; Shen, B.; Wagner, E. M.;
Lanza, G. M. Characterization of early neovascular response to acute
lung ischemia using simultaneous 19F/ H MR molecular imaging.
Angiogenesis 2014, 17 (1), 51−60.
(
16) Deguchi, J. O.; Aikawa, M.; Tung, C. H.; Aikawa, E.; Kim, D. E.;
Ntziachristos, V.; Weissleder, R.; Libby, P. Inflammation in
atherosclerosis: visualizing matrix metalloproteinase action in macro-
phages in vivo. Circulation 2006, 114 (1), 55−62.
1
(
32) Srinivas, M.; Cruz, L. J.; Bonetto, F.; Heerschap, A.; Figdor, C.
(
17) Ibarra, J. M.; Jimenez, F.; Martinez, H. G.; Clark, K.; Ahuja, S. S.
G.; de Vries, I. J. Customizable, multi-functional fluorocarbon
MMP-Activated fluorescence imaging detects early joint inflammation
in collagen-antibody-induced arthritis in CC-chemokine receptor-2-
null mice in vivo. Int. J. Inflammation 2011, 2011, 691587.
1
9
nanoparticles for quantitative in vivo imaging using F MRI and
optical imaging. Biomaterials 2010, 31 (27), 7070−7.
(33) Yue, X. Y.; Taraban, M. B.; Hyland, L. L.; Yu, Y. B. Avoiding
(
18) Matsumura, S.; Aoki, I.; Saga, T.; Shiba, K. A tumor-
steric congestion in dendrimer growth through proportionate
branching: A twist on da Vinci’s rule of tree branching. J. Org.
Chem. 2012, 77 (20), 8879−8887.
environment-responsive nanocarrier that evolves its surface properties
upon sensing matrix metalloproteinase-2 and initiates agglomeration
to enhance T2 relaxivity for magnetic resonance imaging. Mol.
Pharmaceutics 2011, 8 (5), 1970−4.
(34) Corcoran, M. L.; Hewitt, R. E.; Kleiner, D. E., Jr.; Stetler-
Stevenson, W. G. MMP-2: expression, activation and inhibition.
(
19) Xie, J.; Zhang, F.; Aronova, M.; Zhu, L.; Lin, X.; Quan, Q.; Liu,
Enzyme Protein 1996, 49 (1−3), 7−19.
G.; Zhang, G.; Choi, K. Y.; Kim, K.; Sun, X.; Lee, S.; Sun, S.; Leapman,
R.; Chen, X. Manipulating the power of an additional phase: a flower-
like Au-Fe O optical nanosensor for imaging protease expressions in
(35) Ikejiri, M.; Bernardo, M. M.; Bonfil, R. D.; Toth, M.; Chang, M.;
Fridman, R.; Mobashery, S. Potent mechanism-based inhibitors for
3
4
matrix metalloproteinases. J. Biol. Chem. 2005, 280 (40), 33992−4002.
vivo. ACS Nano 2011, 5 (4), 3043−51.
20) Cha, E. J.; Jang, E. S.; Sun, I. C.; Lee, I. J.; Ko, J. H.; Kim, Y. I.;
Kwon, I. C.; Kim, K.; Ahn, C. H. Development of MRI/NIRF
activatable’ multimodal imaging probe based on iron oxide nano-
particles. J. Controlled Release 2011, 155 (2), 152−8.
21) Ansari, C.; Tikhomirov, G. A.; Hong, S. H.; Falconer, R. A.;
(36) Wolters, M.; Mohades, S. G.; Hackeng, T. M.; Post, M. J.; Kooi,
(
M. E.; Backes, W. H. Clinical perspectives of hybrid proton-fluorine
magnetic resonance imaging and spectroscopy. Invest. Radiol. 2013, 48
’
(
5), 341−50.
(
37) Neubauer, A. M.; Myerson, J.; Caruthers, S. D.; Hockett, F. D.;
(
Winter, P. M.; Chen, J. J.; Gaffney, P. J.; Robertson, J. D.; Lanza, G.
M.; Wickline, S. A. Gadolinium-modulated F-19 signals from
perfluorocarbon nanoparticles as a new strategy for molecular imaging.
Magn. Reson. Med. 2008, 60 (5), 1066−1072.
Loadman, P. M.; Gill, J. H.; Castaneda, R.; Hazard, F. K.; Tong, L.;
Lenkov, O. D.; Felsher, D. W.; Rao, J.; Daldrup-Link, H. E.
Development of novel tumor-targeted theranostic nanoparticles
activated by membrane-type matrix metalloproteinases for combined
cancer magnetic resonance imaging and therapy. Small 2014, 10 (3),
(38) de Vries, A.; Moonen, R.; Yildirim, M.; Langereis, S.; Lamerichs,
R.; Pikkemaat, J. A.; Baroni, S.; Terreno, E.; Nicolay, K.; Strijkers, G. J.;
Grull, H. Relaxometric studies of gadolinium-functionalized perfluor-
ocarbon nanoparticles for MR imaging. Contrast Media Mol. Imaging
5
(
66−75 417..
22) Gallo, J.; Kamaly, N.; Lavdas, I.; Stevens, E.; Nguyen, Q. D.;
Wylezinska-Arridge, M.; Aboagye, E. O.; Long, N. J. CXCR4-targeted
and MMP-responsive iron oxide nanoparticles for enhanced magnetic
resonance Imaging. Angew. Chem., Int. Ed. 2014, 53, 9550−9554.
2
(
014, 9 (1), 83−91.
39) Nie, L.; Wang, S.; Wang, X.; Rong, P.; Ma, Y.; Liu, G.; Huang,
P.; Lu, G.; Chen, X. In vivo volumetric photoacoustic molecular
angiography and therapeutic monitoring with targeted plasmonic
nanostars. Small 2014, 10 (8), 1585−93.
(
23) Huang, C. W.; Li, Z.; Conti, P. S. Radioactive smart probe for
potential corrected matrix metalloproteinase imaging. Bioconjugate
Chem. 2012, 23 (11), 2159−67.
(
40) Lanza, G. M.; Winter, P. M.; Neubauer, A. M.; Caruthers, S. D.;
1
19
(
24) van Duijnhoven, S. M.; Robillard, M. S.; Hermann, S.;
Hockett, F. D.; Wickline, S. A. H/ F magnetic resonance molecular
imaging with perfluorocarbon nanoparticles. Curr. Top. Dev. Biol.
2005, 70, 57−76.
Kuhlmann, M. T.; Schafers, M.; Nicolay, K.; Grull, H. Imaging of
MMP activity in postischemic cardiac remodeling using radiolabeled
MMP-2/9 activatable peptide probes. Mol. Pharmaceutics 2014, 11 (5),
(41) Chen, J.; Lanza, G. M.; Wickline, S. A. Quantitative magnetic
resonance fluorine imaging: today and tomorrow. Wiley Interdiscip.
Rev.: Nanomed. Nanobiotechnol. 2010, 2 (4), 431−40.
1
(
415−23.
25) Chuang, C. H.; Chuang, K. H.; Wang, H. E.; Roffler, S. R.;
Shiea, J. T.; Tzou, S. C.; Cheng, T. C.; Kao, C. H.; Wu, S. Y.; Tseng,
W. L.; Cheng, C. M.; Hou, M. F.; Wang, J. M.; Cheng, T. L. In vivo
positron emission tomography imaging of protease activity by
(42) Huang, X.; Huang, G.; Zhang, S.; Sagiyama, K.; Togao, O.; Ma,
X.; Wang, Y.; Li, Y.; Soesbe, T. C.; Sumer, B. D.; Takahashi, M.;
Sherry, A. D.; Gao, J. Multi-chromatic pH-activatable F-MRI
1
9
4
216
dx.doi.org/10.1021/mp500443x | Mol. Pharmaceutics 2014, 11, 4208−4217